logo
Albertsons Companies, Inc. (ACI): The Best Food Stock to Buy Under $30

Albertsons Companies, Inc. (ACI): The Best Food Stock to Buy Under $30

Yahoo07-05-2025
We recently published a list of 12 Best Food Stocks to Buy Under $30. In this article, we are going to take a look at where Albertsons Companies, Inc. (NYSE:ACI) stands against other best food stocks to buy under $30.
Consumer Defensive Sector: Trends and Outlook
On April 25, Shana Sissel, Founder & CEO of Banrion Capital Mgmt, appeared on CNBC to talk about the struggles in the consumer staple sector and investor caution due to tariffs and 'Trump exhaustion.' She said the consumer defensive stocks are going on a downward trend, which makes sense to her, especially if you look at how the market's momentum flows. The concern about a recession and potential economic downturn might be too aggressive. She opined that she wouldn't take it as much of a point right now because even if we are going to see any economic slowdown from tariffs, one thing is certain: consumers do not tend to cut back on staples. The sector includes the types of companies and consumer goods that people cannot and will not live without.
However, even in this sector, there are some unusual economic indicators that may reflect signs of an economic recession. This includes the snack indicator, where people tend to cut back on snacks in tough times instead of staple food items and other more essential nutrition types. While this is something to keep in mind about the sector, Sissel said that how the consumer staples are performing reflects the momentum swing we have seen in the market. The outlook is, of course, concerning, as it is necessary to look at how people are thinking about the market conditions and the effects of tariff impacts.
JP Morgan also recently gave a market outlook amid tariffs, saying that the market is very bearish, especially in the macro community. It further said that:
'Most are disregarding the latest trade developments, partly due to 'Trump exhaustion.' We observe that many prefer to stay in cash and maintain lower leverage in their books.'
Talking about this outlook, Sissel said that one of the triggers that one must look out for a potential change in sentiment is the fact that there is a contrarian sentiment, where we have seen a lot of investors buying the dip. A whole generation of investors has learned to buy the dip because, most of the time, the market recovers quickly.
She also said that the Trump exhaustion appears to be very real, as continuous policy changes have created uncertainty in the market, especially regarding tariffs. While it looks like things are calming down, investors are going to be cautious about jumping in too quickly because of the continuous policy changes. She thus opined that we might see cash staying on the sideline a little bit longer, which meant that we have not seen enough change to indicate that any market gains we are seeing right now are sustainable.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bausch Health (BHC) Climbs 45% on Insider Buying
Bausch Health (BHC) Climbs 45% on Insider Buying

Yahoo

time24 minutes ago

  • Yahoo

Bausch Health (BHC) Climbs 45% on Insider Buying

We recently published . Bausch Health Companies Inc. (NYSE:BHC) is one of the last week's top performers. Bausch Health jumped by 45.04 percent week-on-week, on a combination of bargain-hunting and mirroring an insider purchase last Friday. In a regulatory filing, Bausch Health Companies Inc. (NYSE:BHC) said that Paulson Capital Inc. and its affiliates acquired 34.7 million of its shares from Carl C. Icahn and affiliates, effectively boosting its total ownership to 19.13 percent. Following the transaction that saw the sellers' shares fall below the threshold to earn a board seat, the Icahn Group officially exited Bausch Health Companies Inc.'s (NYSE:BHC) higher management. Copyright: nimon / 123RF Stock Photo Additionally, Brett M. Icahn and Steven D. Miller have resigned from the company's board of directors. In recent news, Bausch Health Companies Inc. (NYSE:BHC) expanded its attributable net income by 1,380 percent in the second quarter of the year to $148 million from only $10 million in the same period last year. Revenues also grew by 5 percent to $2.53 billion from $2.4 billion. While we acknowledge the potential of BHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio

Why IBM's High Valuation Has Analysts Concerned
Why IBM's High Valuation Has Analysts Concerned

Yahoo

time24 minutes ago

  • Yahoo

Why IBM's High Valuation Has Analysts Concerned

International Business Machines Corporation (NYSE:) is one of the On August 14, Erste Group analyst Hans Engel downgraded the stock from Buy to Hold, reflecting the challenges IBM is facing in accelerating its revenue growth to contest broader technology sector performance. According to the analysts, IBM's sales growth is 'well below' the sector average which isn't expected to change this year. They believe that current valuation is 'high in view of the below-average growth prospects.' 'IBM's sales growth is well below the sector average. This is not expected to change this year either. The Group's latest forecast for 2025 assumes moderate revenue growth of at least +5% (y/y). The free cash flow forecast has been left at USD 13.5 bn. The current P/E ratio of the stock is high in view of the below-average growth prospects.' JuliusKielaitis / International Business Machines Corporation (NYSE:IBM) is a multinational technology company and a pioneer in artificial intelligence, offering AI consulting services and a suite of AI software products. While we acknowledge the potential of IBM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Eli Lilly Taps High-Grade Market With Rare 40-Year Paper
Eli Lilly Taps High-Grade Market With Rare 40-Year Paper

Yahoo

time24 minutes ago

  • Yahoo

Eli Lilly Taps High-Grade Market With Rare 40-Year Paper

(Bloomberg) -- Eli Lilly & Co. is tapping the US investment-grade debt market with a deal that's expected to include a 40-year bond, a rarity in a market characterized by high borrowing costs. The drugmaker is selling debt in as many as seven parts, with 40-year tranche set to yield 0.73 percentage point above Treasuries, according to a person familiar with the matter. Initial price discussions called for a yield in the area of 1.05 percentage points above the benchmark. A Photographer's Pipe Dream: Capturing New York's Vast Water System Festivals and Parades Are Canceled Amid US Immigration Anxiety A London Apartment Tower With Echoes of Victorian Rail and Ancient Rome Princeton Plans New Budget Cuts as Pressure From Trump Builds The deal is also expected to include a 30-year portion, as well as maturities ranging from 3 years to 10 years, the person said, asking not to be identified discussing private information. The offering comes amid a dearth of supply of long-dated corporate bonds: Just 11% of high-grade debt sold this year had a maturity of 30 years or more, down from 15% in 2024, as companies have been reticent to lock in elevated borrowing costs for long periods of time. Eli Lilly is one of nine companies selling US high-grade debt on Monday, with McDonald's Corp., Marriott International Inc. and Charter Communications Inc. among the others. Borrowers are piling in ahead of a seasonal slowdown later this month. They're also taking advantage of more favorable funding conditions: Yields this month are sitting consistently below 5% for the first time this year, yet demand continues to be robust. Most recently, investment-grade order books grew to more than five times the size of fresh supply on Wednesday, while borrowers paid just two basis points in new-issue concessions — both better than average so far this year. Citigroup Inc., Goldman Sachs Group Inc., JPMorgan Chase & Co., Mizuho Financial Group Inc. and Morgan Stanley are managing Eli Lilly's sale, with proceeds earmarked for general corporate purposes. The bonds are expected to be rated Aa3 by Moody's Ratings and A+ by S&P Global Ratings. Issuer Profile Debt distribution: LLY US Equity DDIS Capital structure: LLY US Equity CAST Related securities: LLY US Equity RELS Ratings history: LLY US Equity CRPR --With assistance from Michael Gambale and Boris Korby. (Updates with guidance numbers in second paragraph.) Foreigners Are Buying US Homes Again While Americans Get Sidelined What Declining Cardboard Box Sales Tell Us About the US Economy Americans Are Getting Priced Out of Homeownership at Record Rates Living With 12 Strangers to Ease a Housing Crunch Bessent on Tariffs, Deficits and Embracing Trump's Economic Plan ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store